Forget the Oil Crash – Crush the Market With Biotech StocksAdded by Oliver Wright on December 20, 2014.Saved under MoneyTags: Capitalism, Investing, Monetary PolicyThis post Forget the Oil Crash – Crush the Market With Biotech Stocks appeared first on Daily Reckoning.The financial media is playing the “when will oil bottom?” game to help fill the 24-hour news cycle—but that’s not […]
Follow this link:
Biotech investors locking in profit?
See which stocks are being affected by Social Media
[…]
The financial media is playing the “when will oil bottom?” game to help fill the 24-hour news cycle—but that’s not going to make you money.So, today I have a trade that will…Sure, crude just took a breather to plug the leaks. It even jumped a couple of bucks. But when all was said and done yesterday, oil landed right back […]
C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure | Biotech License
Select CategoryBiotech Articles (22)Biotech FAQ (222)Biotech News (465)Biotech Patents (47)Biotech Videos (37)Pharmaceutical News (124)
Link:
C3BS enrols 240th patient in CHART-1 European …
See which stocks are being affected by Social Media
[…]
Source:
Cramer: Watch out Regeneron, here comes Isis
[…]
My afternoon train reads:
• The Best Thing for Active Managers? Passive Investors. — As institutions slash active mandates, managers on both sides of the active versus passive argument rejoice. (Chief Investment Officer)• The Reformed Broker talks markets and investing (Vanguard)• The State of Consumer Technology at the End of 2014 (Stratechery)• What Life in Cuba Was Like After Castro’s Revolution (New Republic)• D.H. Robertson […]
Alibaba founder Jack Ma celebrates its September IPO at the New York Stock Exchange. (AP Photo/Mark Lennihan)
The IPO market is about to put a bow on its busiest year since 2000, but despite a number of huge successes the figures underlying a banner year show new entrants to the market are facing tougher grading from investors.With 273 U.S. IPOs […]
View article:
Forbes: Little Known Biotech For Products With Huge Potential Value
See which stocks are being affected by Social Media
[…]
Since its lows in mid-October, biotech stocks have sparkled, particularly the Big four – Amgen (AMGN), Biogen Idec (BIIB), Celgene (CELG), and Gilead (GILD) – which have demonstrated sustainable growth pathways. With the market’s renewed volatility in recent days, they have pulled back some, which only made them much more reasonably priced.But the more attractive buys in the sector, say […]
Cuba Policy; China (Trade-Biotech); and, the Agricultural EconomyCategories: Agricultural Economy /China /TradeCuba PolicyGeoff Dyer and Marc Frank reported yesterday at The Financial Times Online that, “The US is to open talks with Cuba about establishing full diplomatic relations and reopening an embassy in Havana, potentially bringing to an end more than five decades of hostility and one of the last vestiges […]
